RELATING TO HEALTH AND SAFETY -- LEAD POISONING PREVENTION ACT
Summary
H7191 amends Rhode Island’s Lead Poisoning Prevention Act to change where blood lead screening samples from children under age six may be analyzed. Under current law, those samples must be sent to the state laboratory in the Department of Health or to a clinical laboratory operated by an entity incorporated in Rhode Island. The bill would broaden that rule by expressly allowing a clinical laboratory incorporated in Rhode Island to perform the analysis of those blood samples for lead levels.
The bill also leaves in place the existing framework requiring the Department of Health to set screening intervals and methods, requiring physicians and child-serving health care facilities to ensure screening, and allowing religious objections by parents. It preserves the department’s duty to collect, analyze, and publish annual lead screening data for state agencies, the health care community, the General Assembly, and the public.
Impact
The bill would make a targeted change to Chapter 23-24.6 by clarifying and expanding the list of laboratories that may analyze pediatric blood lead samples, while keeping the state’s screening mandate and reporting system intact. Its practical effect would be on health care providers, laboratories, and the Department of Health, which would continue to oversee lead screening compliance and data reporting. The measure could also affect in-state clinical laboratories by allowing them to participate more directly in lead testing for young children.
Sentiment
No committee transcript or vote record was provided, so there is no documented debate or recorded sentiment to assess. Based on the bill text and caption, the proposal appears administrative and technical in nature, aimed at adjusting laboratory eligibility rather than changing the underlying lead screening requirements. The absence of recorded opposition or support in the provided materials means the overall sentiment cannot be determined from legislative discussion.
Contention
The main point of potential contention is the laboratory requirement: the bill would permit a Rhode Island-incorporated clinical laboratory to analyze lead samples, which may be viewed as a way to support in-state testing capacity and local providers. Because the bill does not include committee testimony or votes, there is no evidence of specific objections, but any debate would likely center on whether the change improves access and efficiency or whether it alters existing public health testing arrangements in a meaningful way.
Allows a clinical laboratory, that is incorporated in the State of Rhode Island, to analyze blood samples, from children under the age of six (6) years, for blood lead levels.
Allows a clinical laboratory, that is incorporated in the State of Rhode Island, to analyze blood samples, from children under the age of six (6) years, for blood lead levels.
Ensures public access to lead service lines to determine the existence of lead within the water connection. This act also ensures mitigation measures and replacement lines are consistent with the current version of 40 C.C.R. 141 Subpart I.
Ensures public access to lead service lines to determine the existence of lead within the water connection. This act also ensures mitigation measures and replacement lines are consistent with the current version of 40 C.C.R. 141 Subpart I.
Allows municipalities to enact ordinances that would permit municipalities and water suppliers to enter properties to perform lead service line replacements and permit tenants to request and schedule private side lead service line replacements.
Allows municipalities to enact ordinances that would permit municipalities and water suppliers to enter properties to perform lead service line replacements and permit tenants to request and schedule private side lead service line replacements.